10x genomics wins permanent injunction against nanostring's cosmx products

10x genomics is seeking additional injunctions to protect its intellectual property pleasanton, calif. , may 17, 2023 /prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against nanostring technologies, inc. (nasdaq: nstg) and nanostring technologies germany gmbh.
NSTG Ratings Summary
NSTG Quant Ranking